Loading...
•
Jun 30, 2022
Edgewell Q3 2022 Earnings Report
Net sales increased by 8.7%, with 9.0% organic growth.
Key Takeaways
Edgewell Personal Care announced strong Q3 fiscal 2022 results, with net sales increasing by 8.7% to $623.8 million and organic net sales growing by 9.0%. The company's adjusted EPS was $0.86, compared to $0.89 in the prior year period. They narrowed the range for adjusted EPS and EBITDA for fiscal year 2022.
Net sales were $623.8 million, an increase of 8.7% compared to the prior year period.
Organic net sales increased 9.0% compared to the prior year period.
Adjusted EPS were $0.86 for the third quarter, compared to $0.89 in the prior year period.
Ended the third fiscal quarter with $182 million in cash on hand.
Edgewell
Edgewell
Edgewell Revenue by Segment
Edgewell Revenue by Geographic Location
Revenue by Segment
Wet Shave Revenue
CapyFin.comSun and Skin Care Revenue
CapyFin.comFeminine Care Revenue
CapyFin.comRevenue by Geographic Location
North America Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company is updating its previously provided outlook assumptions for fiscal 2022 to reflect the impact of third fiscal quarter results and projected impacts of the strengthening of the U.S. dollar against most major currencies.
Positive Outlook
- Organic sales expected to increase approximately 4%
- Adjusted EPS expected to be in the range of $2.50 to $2.60
- Range is updated to reflect year-to-date performance, estimated negative effect of unfavorable foreign currency, and the incremental benefit of share repurchases not included in the previous outlook.
- Fiscal year adjusted gross margin is now expected to decline 390-basis points (previously 350-basis point decline) in equal part due to negative currency impacts and the impact of negative channel and category mix.
- The EPS outlook reflects the impact of total fiscal year-to-date share repurchases through June 30, 2022
Challenges Ahead
- Reported net sales expected to increase approximately 4%
- Includes an estimated 310-basis point negative impact from currency translation (previously 200-basis point negative impact)
- GAAP EPS expected to be in the range of $1.83 to $1.93 (previously $1.93 to $2.21)
- Includes: Restructuring charges, SKU rationalization charges, acquisition and integration costs, Sun Care reformulation costs, value added tax settlement costs, and income from a legal settlement
- Adjusted EBITDA expected to be in the range of $335 to $340 million (previously $330 to $345)
Revenue & Expenses
Visualization of income flow from segment revenue to net income